OpenAI acquires Orchestra Bio to build AI agents that speed up drug development
The Decoder
Publisher
Oct 21, 2026 at 8:34 AM UTC · Updated hace 11 horas · 1 min de lectura
OpenAI acquires Orchestra Bio to build AI agents that speed up drug development The Decoder
Sourced by
Originally reported by The Decoder
NewsLayer coverage based on externally reported material.
The Daily Brief
The onchain economy, before your day starts.
Curated markets, onchain insights, and key headlines — delivered every weekday morning.
Weekdays · Free · ~5 minute read
0
Applause
Was this article helpful?
Article Intelligence
Topics
Sponsored
AdNewsLayer Premium
Unlock deeper intelligence.
Ad-free reading, exclusive research, and real-time onchain insights.
Go Premium

